Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 14, 2019
Factors Influencing Drug Disposition of Monoclonal Antibodies in Inflammatory Bowel Disease: Implications for Personalized MedicinePavine L C Lefevre, Lisa M Shackelton, Niels Vande CasteeleDrugs|June 2, 2023
Targeting IL-23 for IBD: Rationale and Progress to DateSudheer K Vuyyuru, Lisa M Shackelton, Jurij Hanzel, et al.Inflammatory Bowel Diseases|October 10, 2014
Tumor necrosis factor-alpha antagonists twenty years later: what do Cochrane reviews tell us?Anthony A Akobeng, William J Sandborn, Stephen J Bickston, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 8, 2020
Development and Validation of a Clinical Decision Support Tool That Incorporates Pharmacokinetic Data to Predict Endoscopic Healing in Patients Treated With InfliximabNiels Vande Casteele, Vipul Jairath, Jenny Jeyarajah, et al.Journal of Immunological Methods|May 31, 2023
Effect of storage time on peripheral blood mononuclear cell isolation from blood collected in vacutainer CPT™ tubesBryan Linggi, Jonathan Cremer, Zhongya Wang, et al.Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.Journal of Crohn'S & Colitis|July 20, 2024
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY TrialChristopher Ma, Brian G Feagan, Zhongya Wang, et al.Scientific Reports|September 15, 2021
Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitisBryan Linggi, Vipul Jairath, Guangyong Zou, et al.Inflammatory Bowel Diseases|August 20, 2014
Assessment of histologic disease activity in Crohn's disease: a systematic reviewAmirkaveh Mojtahed, Reena Khanna, William J Sandborn, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 24, 2021
A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn's DiseasePavine L C Lefevre, Parambir S Dulai, Zhongya Wang, et al.Pageof 5